(Total Views: 126)
Posted On: 05/02/2022 4:25:55 PM
Post# of 85494
$ACAD News Article - Acadia Pharmaceuticals Announces FDA Advisory Committee Meeting to Review Resubmission of Supplemental New Drug Application for NUPLAZID (pimavanserin) for the Treatment of Alzheimer's Disease Psychosis Scheduled for June 17, 2022 https://marketwirenews.com/news-releases/acad...92957.html
(0)
(0)
My Twitter: WhyteStocks
